Tweak induces proliferation in renal tubular epithelium: A role in uninephrectomy induced renal hyperplasia

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3329-3342

  Sanz, Ana B ^a   Sanchez Niño, Maria Dolores ^a   Izquierdo, Maria Concepcion ^a   Jakubowski, Aniela ^b   Justo, Pilar ^a   Blanco Colio, Luis M ^a   Ruiz Ortega, Marta ^a   Egido, Jesús ^a   Ortiz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b BIOGEN   (United States)

Author keywords

Cyclin; Fn14; Kidney; Mitosis; Tubular cell; TWEAK; Uninephrectomy

Indexed keywords

CYCLIN D1; FOLIC ACID; TNFSF12 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; EPITHELIUM; HYPERPLASIA; KIDNEY; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NEPHRECTOMY; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYCLIN D1; EPITHELIUM; FOLIC ACID; HYPERPLASIA; KIDNEY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRECTOMY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

MUS;

EID: 76749108324     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00766.x     Document Type: Article

References (38)

1. Ortiz A, Justo P, Catalan MP. Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord. 2002, 2:181-92.
2. Sun J, Langer WJ, Devish K. Compensatory kidney growth in estrogen receptor-alpha null mice. Am J Physiol Renal Physiol 2006, 290:F319-23.
3. Flyvbjerg A, Bennett WF, Rasch R. Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent. Kidney Int. 1999, 56:2048-54.
4. Webber EM, Bruix J, Pierce RH. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology. 1998, 28:1226-34.
5. Yamada Y, Webber EM, Kirillova I. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology. 1998, 28:959-70.
6. Chicheportiche Y, Bourdon PR, Xu H. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem. 1997, 272:32401-10.
7. Sanz AB, Moreno JA, Sanchez-Nino MD. TWEAKing renal injury. Front Biosci. 2008, 13:580-9.
8. Campbell S, Michaelson J, Burkly L. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci. 2004, 9:2273-84.
9. Harada N, Nakayama M, Nakano H. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2002, 299:488-93.
10. Tran NL, McDonough WS, Savitch BA. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J Biol Chem. 2005, 280:3483-92.
11. Jakubowski A, Ambrose C, Parr M. TWEAK induces liver progenitor cell proliferation. J Clin Invest. 2005, 115:2330-40.
12. Girgenrath M, Weng S, Kostek CA. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 2006, 25:5826-39.
13. Wiley SR, Winkles JA. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 2003, 14:241-9.
14. Zhao Z, Burkly LC, Campbell S. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol. 2007, 179:7949-58.
15. Sanz AB, Justo P, Sanchez-Nino MD. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol. 2008, 19:695-703.
16. Meighan-Mantha RL, Hsu DK, Guo Y. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem. 1999, 274:33166-76.
17. Justo P, Sanz AB, Sanchez-Nino MD. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 2006, 70:1750-8.
18. Meloche S, Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007, 26:3227-39.
19. Mulloy R, Salinas S, Philips A. Activation of cyclin D1 expression by the ERK5 cascade. Oncogene. 2003, 22:5387-98.
20. Haverty TP, Kelly CJ, Hines WH. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol. 1988, 107:1359-68.
21. Ortiz A, Lorz C, Catalan MP. Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int. 2000, 57:969-81.
22. Campbell S, Burkly LC, Gao HX. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol. 2006, 76:1889-98.
23. Bover LC, Cardo-Vila M, Kuniyasu A. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol. 2007, 178:8183-94.
24. Baxter FO, Came PJ, Abell K. IKKbeta/2 induces TWEAK and apoptosis in mammary epithelial cells. Development. 2006, 133:3485-94.
25. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3:221-7.
26. Firestein GS, Manning AM. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 1999, 42:609-21.
27. Reddy SA, Huang JH, Liao WS. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem. 1997, 272:29167-73.
28. Higashitsuji H, Arii S, Furutani M. Expression of cytokine genes during liver regeneration after partial hepatectomy in rats. J Surg Res. 1995, 58:267-74.
29. Alderson MR, Armitage RJ, Maraskovsky E. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 1993, 178:2231-5.
30. Pearl-Yafe M, Stein J, Yolcu ES. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells. 2007, 25:3194-203.
31. Mitsiades CS, Poulaki V, Fanourakis G. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res. 2006, 12:3705-12.
32. Justo P, Sanz A, Lorz C. Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. Kidney Int Suppl 2003, S52-6.
33. Desplat-Jego S, Varriale S, Creidy R. TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol. 2002, 133:116-23.
34. Lynch CN, Wang YC, Lund JK. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 1999, 274:8455-9.
35. Donohue PJ, Richards CM, Brown SA. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol. 2003, 23:594-600.
36. Ando T, Ichikawa J, Wako M. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 8:R146.
37. Feng F, Wang L, Albanese N. TWEAK attenuates the action of insulin in hepatocytes. Endocrinology. 2008, 149:1505-13.
38. Stalder M, Birsan T, Hausen B. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy. Transpl Int. 2005, 18:1158-65.